Clinical Trial

A Research Study in Children Born Small and Who Stayed Small. Treatment is Somapacitan Once a Week Compared to Norditropin® Once a Day

Active, Not Recruiting Phase 2
View on ClinicalTrials.gov →
Summary
The study compares 2 medicines used for the treatment of children who are born small and who stayed small: somapacitan given once a week (a new medicine) and Norditropin® given once a day (the medicine doctors can already prescribe). Participants will either get somapacitan or Norditropin® - which treatment is decided by chance. Both participants and the study doctor will know which treatment the participants get. The study will last for 5 years. Participants will take either an injection once every week or once every day.
Trial Details
NCT Number NCT03878446
Lead Sponsor Novo Nordisk A/S
Conditions Short Stature Children Born Small for Gestational Age (SGA)
Enrollment 62 participants
Start Date 2019-07-04
Primary Completion 2021-05-05 (estimated)
Study Completion 2026-12-23 (estimated)
Updated on ClinicalTrials.gov 2026-06-10